The Hatch–Waxman Act, enacted nearly 30 years ago, reflects a negotiated balance between making generic drugs more readily accessible and protecting the significant investment made by brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback